Where does Sonoma Biotherapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Sonoma Biotherapeutics's 1 recorded funding rounds.

Premier Alternatives

Sonoma Biotherapeutics

Drug Discovery

Sonoma Biotherapeutics is a private drug discovery company. It has raised $265 million across 1 recorded round; the latest was a $265 million Series B in Aug 2021.

PMV mark · valuation

—

Oct 2026

Priced at

—

Total raised

$265.0M

Last round

Early Stage VC (Series B)

Aug 2021

Cap table — not yet on record

Sonoma Biotherapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on Sonoma Biotherapeutics

·36 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about Sonoma Biotherapeutics

Where does Sonoma Biotherapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Sonoma Biotherapeutics's 1 recorded funding rounds.